Search

Search Constraints

You searched for: Author/Creator Ar, Muhlis Cem

Search Results

1. Comparison of International Prognostic Index and NCCN-IPI in 324 patients with de novo diffuse large B-cell lymphoma: a multi-center retrospective analysis. Issue 5 (3rd May 2016)

3. Third-line treatment with second-generation tyrosine kinase inhibitors (dasatinib or nilotinib) in patients with chronic myeloid leukemia after two prior TKIs: real-life data on a single center experience along with the review of the literature. Issue 4 (21st April 2018)

6. Results of multicenter registry for patients with inherited factor VII deficiency in Turkey. (1st February 2022)

8. Deep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors. Issue 1 (2nd January 2019)

9. Tocilizumab in COVID-19: The Cerrahpaşa-PREDICT score. Issue 9 (September 2021)

10. Imatinib reduces bone marrow fibrosis and overwhelms the adverse prognostic impact of reticulin formation in patients with chronic myeloid leukaemia. Issue 9 (25th January 2016)